Searched for
ZRC 3308
Cadila Healthcare Q1 results: Net profit rises 29% to Rs 587 crConsolidated total revenue from operations stood at Rs 4,025.4 crore for the quarter under consideration against Rs 3,514.6 crore for the s...- Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: SourcesThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...
- GSK gears up to bring antibody cocktail drug to India; Zydus ready for trial“We are exploring all options to quickly make this important medicine available for Indian patients,” GSK India spokesperson told ET. Earli...
- India's Zydus Cadila seeks human trial approval for COVID-19 antibody cocktailRegeneron and Roche's antibody cocktail has also received emergency use approval in India, and will be distributed by drugmaker Cipla. The ...
Load More